Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.

Xie, Xuping; Zou, Jing; Fontes-Garfias, Camila R; Xia, Hongjie; Swanson, Kena A; Cutler, Mark; Cooper, David; Menachery, Vineet D; Weaver, Scott; Dormitzer, Philip R; Shi, Pei-Yong

Xie, Xuping; Zou, Jing; Fontes-Garfias, Camila R; Xia, Hongjie; Swanson, Kena A; Cutler, Mark; Cooper, David; Menachery, Vineet D; Weaver, Scott; Dormitzer, Philip R; Shi, Pei-Yong.

Afiliación

Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX, U.S.A.
Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX, U.S.A.
Fontes-Garfias CR; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX, U.S.A.
Xia H; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX, U.S.A.
Swanson KA; Pfizer, 401 N Middletown Rd., Pearl River, NY 10960, U.S.A.
Cutler M; Pfizer, 401 N Middletown Rd., Pearl River, NY 10960, U.S.A.
Cooper D; Pfizer, 401 N Middletown Rd., Pearl River, NY 10960, U.S.A.
Menachery VD; Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston TX, U.S.A.
Weaver S; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Dormitzer PR; Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston TX, U.S.A.
Shi PY; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.

bioRxiv ; 2021 Jan 07.

Article en En | MEDLINE | ID: mdl-33442691

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google